03 May 2019
Visiongain has launched a new pharma report Top 30 Oncology Drugs Manufacturers 2019: AstraZeneca, Merck, Novartis, Amgen, GlaxoSmithKline, Johnson & Johnson, Roche, Pfizer, Eli Lilly, Other Companies.
The anti-cancer drugs market will continue to increase over the next 10 years, as the incidence of cancer rises around the world. Growth will be driven by the ageing population in both the developed and developing markets. Better accessibility to healthcare and new diagnostic techniques has allowed more cancer cases to be discovered when they can be more easily treated. Continuous research and development will lead to more treatments being available on the market, although the number of big blockbuster drugs will fall as treatment becomes more personalised.
The lead analyst of the report commented "The cancer treating drugs market will continue to grow over the next ten years. Despite generic erosion due to patent expiry on some leading anti-cancer drugs, this market will gain successful new products, including orphan drugs for rare cancers. Many R&D studies focus on immunotherapy and targeted therapy, in line with the increasing interest in personalised medicine."
Leading companies featured in the report include Abbott Laboratories, AbbVie, Amgen, Astellas Pharma, AstraZeneca, Aurora Biophama, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), Celgene Corporation, Eli Lilly, Fresenius Kabi and other companies
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.
26 May 2022
The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.
19 April 2022
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet
13 April 2022
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.